208 related articles for article (PubMed ID: 32986150)
1. Association between cannabinoid 1 receptor availability and glutamate levels in healthy controls and drug-free patients with first episode psychosis: a multi-modal PET and 1H-MRS study.
Borgan F; Veronese M; Reis Marques T; Lythgoe DJ; Howes O
Eur Arch Psychiatry Clin Neurosci; 2021 Jun; 271(4):677-687. PubMed ID: 32986150
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode Psychosis.
Borgan F; Laurikainen H; Veronese M; Marques TR; Haaparanta-Solin M; Solin O; Dahoun T; Rogdaki M; Salokangas RK; Karukivi M; Di Forti M; Turkheimer F; Hietala J; Howes O;
JAMA Psychiatry; 2019 Oct; 76(10):1074-1084. PubMed ID: 31268519
[TBL] [Abstract][Full Text] [Related]
3. The association between
Beck K; Arumuham A; Brugger S; McCutcheon RA; Veronese M; Santangelo B; McGinnity CJ; Dunn J; Kaar S; Singh N; Pillinger T; Borgan F; Sementa T; Neji R; Jauhar S; Aigbirhio F; Boros I; Turkheimer F; Hammers A; Lythgoe D; Stone J; Howes OD
J Psychopharmacol; 2022 Sep; 36(9):1051-1060. PubMed ID: 36120998
[TBL] [Abstract][Full Text] [Related]
4. Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.
Shakory S; Watts JJ; Hafizi S; Da Silva T; Khan S; Kiang M; Bagby RM; Chavez S; Mizrahi R
Neuropsychopharmacology; 2018 Oct; 43(11):2249-2255. PubMed ID: 30087434
[TBL] [Abstract][Full Text] [Related]
5. Glutamate levels in the anterior cingulate cortex in un-medicated first episode psychosis: a proton magnetic resonance spectroscopy study.
Borgan FR; Jauhar S; McCutcheon RA; Pepper FS; Rogdaki M; Lythgoe DJ; Howes OD
Sci Rep; 2019 Jul; 9(1):8685. PubMed ID: 31266965
[TBL] [Abstract][Full Text] [Related]
6. The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study.
Jauhar S; McCutcheon R; Borgan F; Veronese M; Nour M; Pepper F; Rogdaki M; Stone J; Egerton A; Turkheimer F; McGuire P; Howes OD
Lancet Psychiatry; 2018 Oct; 5(10):816-823. PubMed ID: 30236864
[TBL] [Abstract][Full Text] [Related]
7. Glutamatergic basis of antipsychotic response in first-episode psychosis: a dual voxel study of the anterior cingulate cortex.
Fan L; Liang L; Wang Y; Ma X; Yuan L; Ouyang L; He Y; Li Z; Li C; Chen X; Palaniyappan L
Neuropsychopharmacology; 2024 Apr; 49(5):845-853. PubMed ID: 37752221
[TBL] [Abstract][Full Text] [Related]
8. In Vivo Brain Glycine and Glutamate Concentrations in Patients With First-Episode Psychosis Measured by Echo Time-Averaged Proton Magnetic Resonance Spectroscopy at 4T.
Kim SY; Kaufman MJ; Cohen BM; Jensen JE; Coyle JT; Du F; Öngür D
Biol Psychiatry; 2018 Mar; 83(6):484-491. PubMed ID: 29031411
[TBL] [Abstract][Full Text] [Related]
9. Dopamine and Glutamate in Antipsychotic-Responsive Compared With Antipsychotic-Nonresponsive Psychosis: A Multicenter Positron Emission Tomography and Magnetic Resonance Spectroscopy Study (STRATA).
Egerton A; Murphy A; Donocik J; Anton A; Barker GJ; Collier T; Deakin B; Drake R; Eliasson E; Emsley R; Gregory CJ; Griffiths K; Kapur S; Kassoumeri L; Knight L; Lambe EJB; Lawrie SM; Lees J; Lewis S; Lythgoe DJ; Matthews J; McGuire P; McNamee L; Semple S; Shaw AD; Singh KD; Stockton-Powdrell C; Talbot PS; Veronese M; Wagner E; Walters JTR; Williams SR; MacCabe JH; Howes OD
Schizophr Bull; 2021 Mar; 47(2):505-516. PubMed ID: 32910150
[TBL] [Abstract][Full Text] [Related]
10. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
11. The neural and molecular basis of working memory function in psychosis: a multimodal PET-fMRI study.
Borgan F; O'Daly O; Veronese M; Reis Marques T; Laurikainen H; Hietala J; Howes O
Mol Psychiatry; 2021 Aug; 26(8):4464-4474. PubMed ID: 31801965
[TBL] [Abstract][Full Text] [Related]
12. Nature of Glutamate Alterations in Schizophrenia: A Meta-analysis of Proton Magnetic Resonance Spectroscopy Studies.
Merritt K; Egerton A; Kempton MJ; Taylor MJ; McGuire PK
JAMA Psychiatry; 2016 Jul; 73(7):665-74. PubMed ID: 27304221
[TBL] [Abstract][Full Text] [Related]
13. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia.
Reid MA; Salibi N; White DM; Gawne TJ; Denney TS; Lahti AC
Schizophr Bull; 2019 Jan; 45(1):180-189. PubMed ID: 29385594
[TBL] [Abstract][Full Text] [Related]
14. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
[TBL] [Abstract][Full Text] [Related]
15. Cortico-Striatal GABAergic and Glutamatergic Dysregulations in Subjects at Ultra-High Risk for Psychosis Investigated with Proton Magnetic Resonance Spectroscopy.
de la Fuente-Sandoval C; Reyes-Madrigal F; Mao X; León-Ortiz P; Rodríguez-Mayoral O; Solís-Vivanco R; Favila R; Graff-Guerrero A; Shungu DC
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv105. PubMed ID: 26364273
[TBL] [Abstract][Full Text] [Related]
16. Glutamatergic metabolites among adolescents at risk for psychosis.
Demro C; Rowland L; Wijtenburg SA; Waltz J; Gold J; Kline E; Thompson E; Reeves G; Hong LE; Schiffman J
Psychiatry Res; 2017 Nov; 257():179-185. PubMed ID: 28772136
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.
Sherif MA; Cortes-Briones JA; Ranganathan M; Skosnik PD
Eur J Neurosci; 2018 Oct; 48(8):2890-2902. PubMed ID: 29247465
[TBL] [Abstract][Full Text] [Related]
18. Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaboration.
Egerton A; Griffiths K; Casetta C; Deakin B; Drake R; Howes OD; Kassoumeri L; Khan S; Lankshear S; Lees J; Lewis S; Mikulskaya E; Millgate E; Oloyede E; Pollard R; Rich N; Segev A; Sendt KV; MacCabe JH
Neuropsychopharmacology; 2023 Feb; 48(3):567-575. PubMed ID: 36456813
[TBL] [Abstract][Full Text] [Related]
19. Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis.
Bojesen KB; Broberg BV; Fagerlund B; Jessen K; Thomas MB; Sigvard A; Tangmose K; Nielsen MØ; Andersen GS; Larsson HBW; Edden RAE; Rostrup E; Glenthøj BY
Biol Psychiatry; 2021 Feb; 89(3):278-287. PubMed ID: 32928500
[TBL] [Abstract][Full Text] [Related]
20. Glutamatergic dysfunction linked to energy and membrane lipid metabolism in frontal and anterior cingulate cortices of never treated first-episode schizophrenia patients.
Smesny S; Gussew A; Biesel NJ; Schack S; Walther M; Rzanny R; Milleit B; Gaser C; Sobanski T; Schultz CC; Amminger P; Hipler UC; Sauer H; Reichenbach JR
Schizophr Res; 2015 Oct; 168(1-2):322-9. PubMed ID: 26255566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
